MTOR and cancer: A review of an exponentially growing number of publications allows to conclude that anticancer effects of metformin stem from several mechanisms: activation of LKB1/AMPK pathway and subsequent inhibition of the mammalian target of rapamycin (mTOR), induction of cell cycle arrest or apoptosis, inhibition of protein synthesis, activation of the immune system and a possible eradication of cancer stem cells [4].